World's Best Scientists 2026 revealed!
Françoise Brun-Vézinet

Françoise Brun-Vézinet

D-Index & Metrics

Microbiology

D-Index
73
Citations
21250
World Ranking
1640
National Ranking
99

Françoise Brun-Vézinet publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Françoise Brun-Vézinet sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 296 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Françoise Brun-Vézinet D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Françoise Brun-Vézinet sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 73 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Françoise Brun-Vézinet is affiliated with Université Paris Cité in France. Their research activity spans several fields mainly within medicine and immunology and microbiology. The scientist has contributed to subfields including epidemiology, virology, infectious diseases, immunology, and hepatology.

The main topics of Brun-Vézinet's work focus extensively on HIV research and treatment, HIV/AIDS research and interventions, and the development of HIV/AIDS drug treatments. Additional topics covered in their research encompass pneumonia and respiratory infections, Pneumocystis jirovecii pneumonia detection and treatment, hepatitis C virus research, and immune cell function and interaction.

  • Their frequent co-authors include Sophie Matheron, Brigitte Autran, Victoire de Lastours, É. Rouveix, and J. Grenet.

  • The Lancet
  • Clinical Microbiology and Infection
  • The Lancet HIV
  • SSRN Electronic Journal
  • Clinical Infectious Diseases

Recent publications authored or co-authored by Françoise Brun-Vézinet are as follows:

  • Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial, 2021, The Lancet
  • Exclusive oral antibiotic treatment for hospitalized community-acquired pneumonia: a post-hoc analysis of a randomized clinical trial, 2024, Clinical Microbiology and Infection
  • Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial, 2024, The Lancet HIV
  • Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection, 2020, Frontiers in Immunology
  • A Comparison of Cell Activation, Exhaustion, and Expression of HIV Coreceptors and Restriction Factors in HIV-1- and HIV-2-Infected Nonprogressors, 2020, AIDS Research and Human Retroviruses

Best Publications

  • Isolation of a new human retrovirus from West African patients with AIDS.

    F Clavel;D Guétard;F Brun-Vézinet;S Chamaret

  • Identification of a new human immunodeficiency virus type 1 distinct from group M and group O

    François Simon;Philippe Mauclère;Pierre Roques;Ibtissam Loussert-Ajaka

  • Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management

    M S Hirsch;B Conway;R T D'Aquila;V A Johnson

  • Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

    Martin S. Hirsch;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

    Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Francoise Brun-Vezinet

  • Update of the Drug Resistance Mutations in HIV-1: 2005.

    Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • Mechanisms of Virologic Failure in Previously Untreated HIV-Infected Patients From a Trial of Induction-Maintenance Therapy

    D Descamps;P Flandre;V Calvez;G Peytavin

  • Weekly Pulse Methotrexate in Rheumatoid Arthritis: Clinical and Immunologic Effects in a Randomized, Double-Blind Study

    Peter A. Andersen;Sterling G. West;James R. O'dell;Charles S. Via

  • Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.

    Jean-Luc Meynard;Muriel Vray;Laurence Morand-Joubert;Esther Race

  • European guidelines on the clinical management of HIV-1 tropism testing

    L.P.R. Vandekerckhove;Annemarie Wensing;Rolf Kaiser;F. Brun-Vézinet

  • HIV-1/HIV-2 seronegativity in HIV-1 subtype 0 infected patients

    I. Loussert-Ajaka;F. Brun-Vézinet;F. Simon;T.D. Ly

  • A Randomized Trial of Three Maintenance Regimens Given after Three Months of Induction Therapy with Zidovudine, Lamivudine, and Indinavir in Previously Untreated HIV-1–Infected Patients

    Gilles Pialoux;François Raffi;Françoise Brun-Vezinet;Vincent Meiffrédy

  • DETECTION OF IgG ANTIBODIES TO LYMPHADENOPATHY-ASSOCIATED VIRUS IN PATIENTS WITH AIDS OR LYMPHADENOPATHY SYNDROME

    F. Brun-Vezinet;F. Barre-Sinoussi;A.G. Saimot;D. Christol

  • Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.

    D Descamps;G Collin;F Letourneur;C Apetrei

  • Update of the drug resistance mutations in HIV-1: Fall 2006.

    Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Daniel R Kuritzkes

  • Cellular and plasma viral load in patients infected with HIV-2

    F Simon;S Matheron;C Tamalet;I Loussert-Ajaka

  • Identification of a Highly Divergent HIV Type 2 and Proposal for a Change in HIV Type 2 Classification

    Florence Damond;Michael Worobey;Pauline Campa;Isabelle Farfara

  • env Sequences of Simian Immunodeficiency Viruses from Chimpanzees in Cameroon Are Strongly Related to Those of Human Immunodeficiency Virus Group N from the Same Geographic Area

    Sylvie Corbet;Michaela C. Müller-Trutwin;Pierre Versmisse;Severine Delarue

  • Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France.

    I Loussert-Ajaka;M L Chaix;B Korber;F Letourneur

  • Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Clinical and virological features in four patients.

    F. Brun-Vezinet;C. Katlama;D. Roulot;L. Lenoble

  • Update of the drug resistance mutations in HIV-1: December 2009.

    Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard

Frequent Co-Authors

François Simon
François Simon Université Paris Cité
Sophie Matheron
Sophie Matheron Université Paris Cité
Gilles Peytavin
Gilles Peytavin Claude Bernard University Lyon 1
Geneviève Chêne
Geneviève Chêne University of Bordeaux
Bernard Masquelier
Bernard Masquelier University of Bordeaux
Florence Damond
Florence Damond Hôpital Bichat-Claude-Bernard
Catherine Tamalet
Catherine Tamalet Aix-Marseille University
Jacques Izopet
Jacques Izopet Federal University of Toulouse Midi-Pyrénées

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to a variety of related careers and educational paths. For those interested in healthcare, becoming a functional nurse practitioner can be a rewarding option, leveraging biological knowledge to provide holistic patient care.

Students with unique backgrounds may find hope in tailored programs designed to support second chances. Online education platforms provide some of the degrees felons can get, allowing individuals to rebuild their careers and contribute meaningfully to fields like microbiology and public health.

For those drawn to specialized healthcare roles beyond direct patient care, becoming a CPC (Certified Professional Coder) offers a viable pathway. This career focuses on medical coding, crucial for healthcare administration and billing.

Additionally, careers such as child life specialists salary indicate opportunities where understanding biology can improve patient outcomes in pediatric settings. These diverse pathways complement microbiology studies by combining science with practical applications in health and wellness sectors.

Best Scientists Citing Françoise Brun-Vézinet

Trending Scientists

Recently Published Articles